| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| GTO ID | GTC3105 |
| Trial ID | NCT05445765 |
| Disease | Hematologic Cancer | Acute Myeloid Leukemia |
| Altered gene | CD33 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD33 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | iCell Gene Therapeutics |
| Other ID(s) | ICG165-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||